| Literature DB >> 34306853 |
Joseph L Reno1, Meghan I Cook2, Michael Kushelev3, Blair H Hayes3, John Coffman3.
Abstract
Anesthetic implications for morbidly obese parturients have been well described; however, the literature has not yet clarified whether there are additional or unique concerns if the body mass index (BMI) rises farther above the so-called super morbid obesity level: BMI >50 kg/m2. There have only been a few case reports focusing on patients with BMI close to or above 100. Parturients with BMI significantly greater than 50 are uncommon, but they represent an increasing proportion among the morbidly obese. In this report, we present the use of continuous spinal anesthesia in consecutive cesarean deliveries for a patient with a BMI of 102 at her first delivery and 116 at her second. For both deliveries, an intrathecal catheter dosing incrementally provided effective anesthesia with a cumulative dose of hyperbaric bupivacaine 12 mg, fentanyl 15 mcg, and morphine 100 mcg given in 0.25-ml increments over 12 minutes, with 0.25-ml sterile saline flushes between doses. While dosing the catheter, the patient was gradually lowered to a 30° semi-recumbent position for surgery. This strategy minimized the risk of high spinal block or respiratory distress. She did not develop any postdural puncture headache (PDPH). This case report offers an extreme example and provides estimates towards adjusting staffing, equipment, location, timing, positioning, anesthetic technique, and dosing for cesarean deliveries in patients with very high BMI levels.Entities:
Keywords: cesarean; continuous spinal anesthesia; intrathecal catheter; obesity; postdural puncture headache; team coordination
Year: 2021 PMID: 34306853 PMCID: PMC8279172 DOI: 10.7759/cureus.15643
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Case details during first and second cesarean deliveries
LOR: loss of resistance; OR: operating room; CPAP: continuous positive airway pressure; ICU: intensive care unit
| Variables | First delivery | Second delivery |
| Body mass index (kg/m2) | 102 | 116 |
| Weight (kg) | 279 | 315 |
| Height (cm) | 165 | 165 |
| Gestational age (weeks, days) | 39, 2 | 36, 4 |
| Urgency and indication for cesarean | Elective, breech presentation | Elective, previous classical hysterotomy |
| Anesthetic technique | L3/4 intrathecal catheter. Tape retraction, landmark-guided. Used 15-cm, 17-G Tuohy epidural needle. LOR 13 cm, threaded 6 cm | L3/4 intrathecal catheter. Tape retraction, landmark-guided. Used 17-cm, 17G-Gertie MarxTM epidural needle. LOR 15 cm, threaded 6 cm |
| Neuraxial procedure (minutes) | 45, in OR | 35, out of OR |
| Anesthetic dose | Intrathecal: bupivacaine 12 mg, fentanyl 15 mcg, morphine 100 mcg; given in 0.25-ml increments, 0.25-ml saline flush, dosed over 12 minutes. To T4 level | Intrathecal: bupivacaine 12 mg, fentanyl 15 mcg, morphine 100 mcg; given in 0.25-ml increments, 0.25-ml saline flush, dosed over 12 minutes. To T4 level. Before closure: bupivacaine 1.875 mg (0.25 ml) |
| Surgical details | Semi-recumbent position, midline supraumbilical skin incision, classical (fundal) hysterotomy | Semi-recumbent position, midline supraumbilical skin incision, classical (fundal) hysterotomy |
| OR location | Obstetric unit | Main OR suite |
| Time from incision to closure (minutes) | 68 | 92 |
| Total time in OR (minutes) | 176 | 131 |
| Vasopressor intraoperative support | Phenylephrine infusion of 20-50 mcg/minute | Phenylephrine infusion of 25-50 mcg/minute |
| Estimated blood loss (ml) | 700 | 800 |
| Apgar score (1, 5 minutes) | 1, 8 | 6, 9 |
| Respiratory support | Intraoperative: nasal cannula, CPAP available. Postpartum: CPAP when asleep, continuous SpO2 | Intraoperative: simple face mask, CPAP available. Postpartum: CPAP when asleep, continuous SpO2 |
| Recovery unit | ICU for 24 hours then continuous SpO2-capable ward | Continuous SpO2-capable ward |
| Postdural puncture headache | No | No |
Anesthetic considerations for cesarean deliveries in morbidly obese parturients
BMI: body mass index (in kg/m2); BP: blood pressure; IV: intravenous; CPAP: continuous positive airway pressure; OR: operating room; CSE: combined spinal-epidural; PDPH: postdural puncture headache; SpO2: pulse oximetry
| Typical considerations with morbid obesity (BMI >40) | Additional considerations with BMI significantly higher than 50 |
| Comorbidities require preoperative optimization and perioperative management | Pulmonary function and limitations verified in operative position(s) |
| Predelivery anesthesia consult for discussion of BMI-adjusted plan and risks | Semi-recumbent (30-45°) intraoperative position: coordinate with the surgeon, most ramps not high enough |
| Intrapartum cesarean more likely | Intraoperative CPAP discussed preoperatively and made available |
| Neuraxial placement likely to be more prolonged and/or difficult (or impossible), ultrasound may aid success | Longer time in OR (neuraxial block + positioning + surgical time) scheduled, anticipated in the anesthesia plan |
| Epidural block more likely to fail | OR table and perioperative bed(s) weight and dimension limits verified |
| Invasive BP monitor is common, and IV lines (and arterial line) often require ultrasound | Extra staff assigned for transferring and positioning |
| Ramp used for intraoperative position | Back-up anesthesia staff considered, in case of prolonged case |
| Anticipate, prepare for difficult mask or intubation | Longer neuraxial needles (epidural and spinal) made available |
| IV doses adjusted | Gradual, incremental dosing of the neuraxial catheter to minimize the risk of high block or respiratory distress |
| Difficult airway cart on hand | If sequential CSE is performed, consider lower spinal dose followed by gradual dosing of the catheter |
| PDPH likely to be less common | |
| Postpartum care on unit with advanced capabilities: (invasive BP, continuous SpO2, CPAP) | |
| Multimodal analgesia planned, with escalation made available instead of relying on IV opioids |